Novel PD-1 blockade bioassay to assess therapeutic antibodies in PD-1 and PD-L1 immunotherapy programs

被引：9
|
作者：
Cheng, Zhi-Jie Jey [1 ]
Karassina, Natasha [1 ]
Grailer, Jamison [1 ]
Hartnett, Jim [1 ]
Fan, Frank [1 ]
Cong, Mei [1 ]
机构：
[1] Promega Corp, Madison, WI USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-5440
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5440
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
    Xin Wang
    Gaochao Guo
    Hui Guan
    Yang Yu
    Jie Lu
    Jinming Yu
    Journal of Experimental & Clinical Cancer Research, 38
  • [22] Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
    Wang, Xin
    Guo, Gaochao
    Guan, Hui
    Yu, Yang
    Lu, Jie
    Yu, Jinming
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
  • [23] Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer
    Wu, Bogang
    Sun, Xiujie
    Gupta, Harshita B.
    Yuan, Bin
    Li, Jingwei
    Ge, Fei
    Chiang, Huai-Chin
    Zhang, Xiaowen
    Zhang, Chi
    Zhang, Deyi
    Yang, Jing
    Hu, Yanfen
    Curiel, Tyler J.
    Li, Rong
    ONCOIMMUNOLOGY, 2018, 7 (11):
  • [24] The therapeutic potential of PD-1/PD-L1 blockade in smoking exposed emphysema
    Kim, Jiseon
    Kim, Na Hyun
    Shon, Chang-Ho
    Huh, Jin-Young
    Han, Kyung Yeon
    Kim, Kyu-Tae
    Shin, Sun Hye
    Park, Hye Yun
    Lee, Sei Won
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [25] Relevance of host and tumor PD-L1 expression in PD-L1 and PD-1 blockade
    Lin, Heng
    Wei, Shuang
    Vatan, Linda
    Kryczek, Ilona
    Zou, Weiping
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [26] PD-L1/PD-1 presence in the tumor microenvironment and activity of PD-1 blockade in multiple myeloma
    B Paiva
    A Azpilikueta
    N Puig
    E M Ocio
    R Sharma
    B O Oyajobi
    S Labiano
    L San-Segundo
    A Rodriguez
    I Aires-Mejia
    I Rodriguez
    F Escalante
    A G de Coca
    A Barez
    J F San Miguel
    I Melero
    Leukemia, 2015, 29 : 2110 - 2113
  • [27] Divergent Expression of PD-1 as Challenges and Chances of Immunotherapy Targeting PD-1 or PD-L1 in Cancer
    Huang, Haozhe
    BIOINFORMATICS AND BIOMEDICAL ENGINEERING, PT II, IWBBIO 2024, 2024, 14849 : 55 - 69
  • [28] PD-L1/PD-1 presence in the tumor microenvironment and activity of PD-1 blockade in multiple myeloma
    Paiva, B.
    Azpilikueta, A.
    Puig, N.
    Ocio, E. M.
    Sharma, R.
    Oyajobi, B. O.
    Labiano, S.
    San-Segundo, L.
    Rodriguez, A.
    Aires-Mejia, I.
    Rodriguez, I.
    Escalante, F.
    de Coca, A. G.
    Barez, A.
    San Miguel, J. F.
    Melero, I.
    LEUKEMIA, 2015, 29 (10) : 2110 - 2113
  • [29] Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade
    Pang, Kun
    Shi, Zhen-Duo
    Wei, Liu-Ya
    Dong, Yang
    Ma, Yu-Yang
    Wang, Wei
    Wang, Guang-Yue
    Cao, Ming-Yang
    Dong, Jia-Jun
    Chen, Yu-Ang
    Zhang, Peng
    Hao, Lin
    Xu, Hao
    Pan, Deng
    Chen, Zhe-Sheng
    Han, Cong-Hui
    DRUG RESISTANCE UPDATES, 2023, 66
  • [30] PD-1/PD-L1 blockade in renal cell cancer
    Beckermann, Kathryn E.
    Johnson, Douglas B.
    Sosman, Jeffrey A.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (01) : 77 - 84
12345